Moretti Morgana, Valvassori Samira S, Varela Roger B, Ferreira Camila L, Rochi Natalia, Benedet Joana, Scaini Giselli, Kapczinski Flávio, Streck Emilio L, Zugno Alexandra I, Quevedo João
Laboratory of Neurosciences and National Institute for Translational Medicine, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Brazil.
Behav Pharmacol. 2011 Dec;22(8):766-72. doi: 10.1097/FBP.0b013e32834d0f1b.
The present study investigated the effect of the histone deacetylase inhibitor, sodium butyrate (SB), on locomotor behavior and on mitochondrial respiratory-chain complexes activity in the brain of rats subjected to an animal model of mania induced by d-amphetamine (d-AMPH). In the reversal treatment, Wistar rats were first treated with d-AMPH or saline (Sal) for 14 days. Thereafter, between days 8 and 14, rats were administered SB or Sal. In the prevention treatment, rats were treated with SB or Sal for 14 days and received d-AMPH or Sal between days 8 and 14. The d-AMPH treatment increased locomotor behavior in Sal-treated rats under reversion and prevention treatment, and SB reversed and prevented d-AMPH-related hyperactivity. Moreover, d-AMPH decreased the activity of mitochondrial respiratory-chain complexes in Sal-treated rats in the prefrontal cortex, hippocampus, striatum, and amygdala in both experiments, and SB was able to reverse and prevent this impairment. The present study suggests that the mechanism of action of SB involves induction of mitochondrial function in parallel with behavioral changes, reinforcing the need for more studies on histone deacetylase inhibitors as a possible target for new medications for bipolar disorder treatment.
本研究调查了组蛋白去乙酰化酶抑制剂丁酸钠(SB)对采用d-苯丙胺(d-AMPH)诱导的躁狂症动物模型的大鼠的运动行为及大脑线粒体呼吸链复合物活性的影响。在逆转治疗中,将Wistar大鼠先用d-AMPH或生理盐水(Sal)处理14天。此后,在第8天至第14天期间,给大鼠施用SB或Sal。在预防治疗中,大鼠用SB或Sal处理14天,并在第8天至第14天期间接受d-AMPH或Sal。在逆转和预防治疗中,d-AMPH处理增加了Sal处理大鼠的运动行为,且SB逆转并预防了与d-AMPH相关的多动。此外,在两个实验中,d-AMPH均降低了Sal处理大鼠前额叶皮质、海马体、纹状体和杏仁核中线粒体呼吸链复合物的活性,且SB能够逆转并预防这种损伤。本研究表明,SB的作用机制涉及线粒体功能的诱导以及行为变化,这进一步强调了需要对组蛋白去乙酰化酶抑制剂开展更多研究,将其作为双相情感障碍治疗新药物的可能靶点。